Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2000-02-07
2001-03-06
Saidha, Tekchand (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S198000, C435S320100, C536S023200, C530S350000
Reexamination Certificate
active
06197569
ABSTRACT:
BACKGROUND OF THE INVENTION
Inflammatory and degenerative disorders account for a significant number of debilitating diseases. Inflammatory states, such as arthritis, psonrasis, asthma, and possibly atherosclerosis, stem from inflammatory reactions in the joints, skin, and blood vessels. It is generally believed that a central role in the inflammatory reaction is the production of phospholipid metabolites called eicosanoids. The eicosanoids represent a family of important mediators such as the leukotrienes, prostaglandins, lipoxins, hydroxy eicosatetreanoic acid, and thromboxanes. It is believed that the generation of eicosanoids is dependent on the availability of arachidonic acid which is liberated from phospholipids by the action of phospholipase A
2
(EC 3.1.1.4).
Phospholipase A
2
(PLA
2
) is the common name for phosphatide 2-acylhydrolase, which catalyzes the hydrolysis of the sn-2-acyl ester bond of phosphoglycerides which results in the production of equimolar amounts of lysophospholipids and free fatty acids. see, E. A. Dennis, T
HE
E
NZYMES
, Vol. 16, Academic Press, New York, (1983). Phospholipase A
2
enzymes are found in all living species and form a diverse family of enzymes. Over eighty phospholipase A
2
enzymes have been structurally characterized, and they show a high degree of sequence homology. J. Chang, et al.,
Biochemical Pharmacology
, 36:2429-2436, (1987); F. F. Davidson and E. A. Dennis,
Journal of Molecular Evolution
, 31:228-238 (1990).
The best characterized varieties of PLA
2
enzyme are the secreted forms, which are released into the extracellular environment where they aid in the digestion of biological materials. The secreted forms have a molecular weight of about 12-15,000 (Davidson and Dennis, supra). In contrast, cytosolic phospholipases A
2
are found in small amounts within the cell and play a key role in the biosynthetic pathway leading to the formation of the platelet activating factors and the eicosanoids. R. M. Kramer, S
IGNAL
-A
CTIVATED
P
HOSPHOLIPASES
, (M. Liscontdi, ed. 1994) pp. 13-30; J. D. Sharp, et al.,
Journal of Biological Chemistry
, 266:14850-14853 (1991).
The cytosolic phospholipases A
2
have a molecular weight of approximately 85,000 daltons. J. D. Clark, et al., Cell, 65:1043-1051 (1991). Free arachidonic acid is the rate limiting precursor for the production of eicosanoids and is liberated from its membrane phospholipid store by the action of cytosolic PLA
2
. E. A Dennis,
Drug Development and Research
, 10:205-220, (1987). The same enzymatic step also produces lysophospholipids which may be converted to platelet-activating factors. Thus, it is believed that cytosolic PLA
2
is central to the regulation of the biosynthetic pathways of potent lipid mediators of inflammation.
Recent studies have begun to indicate that a major component of the pathology of Alzheimer's disease is chronic inflammation. See, J. Schnabel,
Science
, 260:1719-1720 (1993). Indeed, pathological investigations have demonstrated the presence of glial hyperactivity, acute phase proteins, and complement factors within affected areas of the brains of persons affected with Alzheimer's disease. Administration of nonsteroidal anti-inflammatory drugs appears to slow the advance of Alzheimer's disease. Id. Understanding this inflammatory component of Alzheimeres disease, therefore, will lead to advances in novel methods of treating patients suffering from this disease.
Due to the central role in the inflammatory component of Alzheimer's disease that appears to be played by cytosolic phospholipase A
2
, it is desirable to identify and characterize new inhibitors of this enzyme. The present invention provides a novel phospholipase A
2
, nucleic adds encoding this enzyme, and assays which may be employed to identify inhibitors having a therapeutic benefit.
SUMMARY OF THE INVENTION
This invention provides an isolated ainio acid compound useful as a phospholipase A
2
, said compound comprising the amino acd sequence
Met Met Pro Ala Glu Arg Arg Leu Pro Leu Ser Phe Val Leu Asp Val
1 5 10 15
Leu Glu Gly Arg Ala Gln His Pro Gly Val Leu Tyr Val Gln Lys Gln
20 25 30
Cys Ser Asn Leu Pro Ser Glu Leu Pro Gln Leu Leu Pro Asp Leu Glu
35 40 45
Ser His Val Pro Trp Ala Ser Glu Ala Leu Gly Lys Met Pro Asp Ala
50 55 60
Val Asn Phe Trp Leu Gly Glu Ala Ala Ala Val Thr Ser Leu His Lys
65 70 75 80
Asp His Tyr Glu Asn Leu Tyr Cys Val Val Ser Gly Glu Lys His Phe
85 90 95
Leu Phe His Pro Pro Ser Asp Arg Pro Phe Ile Pro Tyr Glu Leu Tyr
100 105 110
Thr Pro Ala Thr Tyr Gln Leu Thr Glu Glu Gly Thr Phe Lys Val Val
115 120 125
Asp Glu Glu Ala Met Glu Lys Ala Glu Val Ser Arg Thr Cys Leu Leu
130 135 140
Thr Val Arg Val Leu Gln Ala His Arg Leu Pro Ser Lys Asp Leu Val
145 150 155 160
Thr Pro Ser Asp Cys Tyr Val Thr Leu Trp Leu Pro Thr Ala Cys Ser
165 170 175
His Arg Leu Gln Thr Arg Thr Val Lys Asn Ser Ser Ser Ser Val Trp
180 &e
Choiu Xue-Chiou C.
Kramer Ruth M.
Pickard Richard T.
Sharp John D.
Strifler Beth A.
Eli Lilly and Company
Saidha Tekchand
Wilson Alexander
LandOfFree
Human phospholipase A2 and related nucleic acid compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human phospholipase A2 and related nucleic acid compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human phospholipase A2 and related nucleic acid compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2451005